Rheumatoid Arthritis: Page 1 Rheumatoid Arthritis: Comparison of Treatment with
Monophenylbutazone and Phenylbutazone SUMMARY. . A double-blind trial has been carried …

Studies in Europe on parenteral use of aminopyrine necessitated the development of a
solvent, and a pyrazol synthetic derivative, phenylbutazone (butazolidin®), was developed …

Different doses of phenylbutazone have been compared in a double blind study on 32
patients with rheumatoid arthritis in order to determine the minimum effective dose. Of 8 …

Phenylbutazone (butazolidin®) is one of a group of pyrazole derivatives developed by the
chemists of the JR Geigy Co., of Basel, Switzerland, in an attempt to find compounds with …

A clinical trial of phenylbutazone in high dose (300 mg daily) and low dose (50 mg daily) is
presented. 2. By analysis of the data by different methods, significant differences in clinical …

Wilhelmi (1949) showed that under the influence of phenylbutazone the pain threshold to
electrical stimulation of the pulp of the incisor teeth in rabbits was raised. The development …

No cases of acute rheumatic fever were included in the study. In about 114 of the cases in
the trial the exacerbation of the chronic rheumatoid arthritis was superimposed on …

Phenylbutazone (Butazolidin) and Butapyring Page 1 Phenylbutazone (Butazolidin) and
Butapyring A Study of Clinical Effects in Arthritis and Gout WILLIAM C. KUZELL, MD, and …

1. The long-term therapeutic value of phenylbutazone (Butazolidin) has been studied in 93
patients with rheumatoid arthritis and objective measurements of therapeutic effectiveness …

The antiphlogistic, analgesic and antipyretic effects of Butazolidin have been so well
documented as a result of numerous studies that it is unnecessary to discuss them in detail …